Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial

Trial Profile

Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Feb 2010

At a glance

  • Drugs IVN 201 (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 17 Feb 2010 Actual end date changed from Mar 2009 to Feb 2010 as reported by ClinicalTrials.gov.
    • 17 Feb 2010 Last checked against ClinicalTrials.gov record.
    • 19 Mar 2009 Results have been reported in an ImVisioN media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top